Share on StockTwits

IRIDEX (NASDAQ:IRIX) Director James B. Hawkins sold 9,786 shares of IRIDEX stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $8.11, for a total value of $79,364.46. Following the completion of the transaction, the director now directly owns 31,294 shares of the company’s stock, valued at approximately $253,794. The sale was disclosed in a filing with the SEC, which is available at this link.

IRIDEX (NASDAQ:IRIX) traded up 0.13% during mid-day trading on Friday, hitting $7.89. 9,148 shares of the company’s stock traded hands. IRIDEX has a 52 week low of $5.72 and a 52 week high of $11.00. The stock has a 50-day moving average of $7.93 and a 200-day moving average of $8.48. The company has a market cap of $77.9 million and a price-to-earnings ratio of 48.94.

IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.